X100 with Full Field Peripheral Blood Smear (PBS) Application

The X100 with Full Field Peripheral Blood Smear Application is an automated digital microscopy system designed to enhance the efficiency and standardization of peripheral blood smear analysis by locating, imaging, and pre-classifying blood cells for technologist review. It leverages oil-free high-resolution imaging technology combined with artificial neural networks to assist in performing WBC differentials, RBC morphology evaluations, and platelet estimations, demonstrating substantial equivalence to traditional manual methods in performance studies.

The Scopio Labs X100 with Full Field Peripheral Blood Smear (PBS) Application is an in vitro diagnostic device designed to assist qualified technologists in hematological analysis. It automates the process of locating and displaying high-resolution digital images of white blood cells (WBCs), red blood cells (RBCs), and platelets from fixed and Romanowsky-stained peripheral blood smears. The system employs a unique image acquisition technique, capturing multiple images under various illumination conditions to reconstruct a 100X equivalent magnification image without immersion oil. For WBC differentials, it utilizes artificial neural networks (ANNs) for automated detection and pre-classification into 18 distinct categories, which the user then reviews and can modify; RBC morphology is characterized by the user based on presented images, and platelet estimation is initially automated with subsequent user review and adjustment capabilities. Performance evaluation of the X100 system, through a method comparison study involving 645 specimens against manual light microscopy, demonstrated strong concordance for key hematological parameters. For WBC differentials, the device showed high correlation coefficients (e.g., 98% for neutrophils, 96% for lymphocytes) and an overall efficiency of 96.29%, with a sensitivity of 87.86% and specificity of 97.62%. RBC morphology evaluation yielded a very high overall agreement of 99.77% with the manual method, and platelet estimation achieved a correlation coefficient of 94%, an efficiency of 94.89%, sensitivity of 90.00%, and specificity of 96.28%. Comprehensive precision studies, adhering to CLSI EP05-A3 guidelines for repeatability and reproducibility across multiple sites, further validated the device's consistent and reliable performance.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the oil-free 100X reconstructed image quality of the X100 system compare to traditional oil immersion microscopy in terms of resolving subtle cellular details critical for diagnosing rare or complex hematological conditions?; What is the observed impact of the expanded 18-category WBC pre-classification system on workflow efficiency, diagnostic accuracy, and learning curve for technologists with varying levels of experience?; Does the X100 system's Artificial Neural Network architecture allow for site-specific calibration or user-feedback-based retraining to improve its classification accuracy for particularly challenging or locally prevalent abnormal cell morphologies?; What is the quantitative difference in average turnaround time for a complete peripheral blood smear analysis (WBC differential, RBC morphology, and platelet estimate) using the X100 system compared to fully manual methods in a typical high-volume clinical laboratory setting?; Are there specific RBC morphological abnormalities or platelet clumping/abnormality scenarios where the X100's automated detection and estimation show limitations compared to expert manual review, and how are these instances flagged or managed within the system's workflow?